SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,698,000 | +7.5% | 70,000 | -6.7% | 1.22% | -11.5% |
| Q2 2020 | $12,744,000 | +29.9% | 75,000 | -11.8% | 1.38% | +0.2% |
| Q1 2020 | $9,807,000 | -28.5% | 85,000 | -29.2% | 1.37% | -8.6% |
| Q4 2019 | $13,711,000 | +8.0% | 120,000 | -19.3% | 1.50% | -5.6% |
| Q3 2019 | $12,699,000 | +35.5% | 148,700 | +9.8% | 1.59% | +54.3% |
| Q2 2019 | $9,369,000 | -15.1% | 135,374 | -10.1% | 1.03% | -20.0% |
| Q1 2019 | $11,030,000 | -19.6% | 150,598 | -37.8% | 1.29% | -17.8% |
| Q4 2018 | $13,723,000 | -1.1% | 242,198 | +34.6% | 1.57% | +12.8% |
| Q3 2018 | $13,882,000 | -9.1% | 180,000 | -21.7% | 1.39% | -11.0% |
| Q2 2018 | $15,270,000 | +124.4% | 230,000 | +76.9% | 1.56% | +86.3% |
| Q1 2018 | $6,804,000 | – | 130,000 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 44,100,294 | $2,381,857,000 | 21.61% |
| Lagoda Investment Management, L.P. | 567,057 | $30,627,000 | 9.21% |
| Redmile Group, LLC | 1,781,470 | $96,217,000 | 7.65% |
| Boxer Capital, LLC | 232,600 | $12,563,000 | 5.63% |
| NEXTHERA CAPITAL LP | 111,500 | $6,022,000 | 3.70% |
| Eventide Asset Management | 835,506 | $45,126,000 | 2.76% |
| WASATCH ADVISORS LP | 2,844,908 | $153,653,000 | 2.29% |
| Opus Point Partners Management, LLC | 67,953 | $3,670,000 | 2.06% |
| CORRADO ADVISORS, LLC | 43,050 | $2,325,000 | 1.48% |
| Baillie Gifford | 16,795,793 | $907,142,000 | 1.42% |